GeoVax director granted 6,000 stock options

GeoVax Labs, Inc. director John N. Spencer Jr reported receiving a grant of stock options covering 6,000 shares of GeoVax common stock.

Rhea-AI Filing Summary

GeoVax Labs, Inc. director John N. Spencer Jr reported receiving a grant of stock options covering 6,000 shares of GeoVax common stock. The options have an exercise price of $1.18 per share, become exercisable on June 17, 2027, and expire on June 17, 2036. Following this grant, he holds 6,000 stock options directly.

Insider Trade Summary

Grant/Award: 6,000 shares

Grant/Award 1 txn

Insider SPENCER JOHN N JR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	6,000	$0.00	$0.00

Holdings After Transaction: Stock Option — 6,000 contracts (Direct)

Key Figures

Options granted: 6,000 options Exercise price: $1.18 per share Options after transaction: 6,000 options +2 more

5 metrics

Options granted 6,000 options Stock option grant to director

Exercise price $1.18 per share Stock option strike price

Options after transaction 6,000 options Total derivative holdings following grant

Vesting date June 17, 2027 Option exercise date

Expiration date June 17, 2036 Option term end

Key Terms

Stock Option, Grant, award, or other acquisition, Common Stock

3 terms

Stock Option financial

"security_title: "Stock Option" for the derivative transaction"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Common Stock financial

"underlying_security_title: "Common Stock" linked to the options"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GeoVax (GOVX) report in this Form 4?

GeoVax reported that director John N. Spencer Jr received a grant of 6,000 stock options. These options relate to GeoVax common stock and were acquired as a compensation award, not through an open-market purchase or sale.

What is the exercise price of the new GeoVax (GOVX) stock options?

The granted stock options have an exercise price of $1.18 per share. This is the fixed price at which the director can buy GeoVax common stock under the option terms once the options become exercisable.

When do the GeoVax (GOVX) options granted to the director vest and expire?

The options become exercisable on June 17, 2027, and expire on June 17, 2036. This provides a roughly nine-year window after vesting during which the director can choose to exercise the options.

How many GeoVax (GOVX) options does the director hold after this transaction?

After this transaction, the director is reported as holding 6,000 stock options. This figure reflects his direct derivative holdings following the grant disclosed in the Form 4, according to the filing data.

Was this GeoVax (GOVX) insider transaction a market buy or sell?

No, this transaction was a grant or award acquisition of stock options, not a market buy or sell. The Form 4 uses code “A,” which indicates a grant, award, or other acquisition of derivative securities as compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 04:22 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SPENCER JOHN N JR

(Last) (First) (Middle)

1955 LAKE PARK DRIVE

SUITE 300

(Street)

SMYRNA GEORGIA 30080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GeoVax Labs, Inc. [ GOVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$1.18	06/17/2026		A		6,000		06/17/2027	06/17/2036	Common Stock	6,000	$0	6,000	D

Explanation of Responses:

	/s/ John N. Spencer, Jr.	06/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)